|
VEZT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.33340005492988E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67660000000214E-07 |
| Normal-vs-Stage2 |
1.24239999998998E-06 |
| Normal-vs-Stage3 |
2.19519957767034E-11 |
| Normal-vs-Stage4 |
4.52540227513509E-11 |
| Stage1-vs-Stage2 |
4.151600E-01 |
| Stage1-vs-Stage3 |
8.321900E-03 |
| Stage1-vs-Stage4 |
1.578740E-03 |
| Stage2-vs-Stage3 |
2.357800E-01 |
| Stage2-vs-Stage4 |
7.360100E-02 |
| Stage3-vs-Stage4 |
4.479600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23109999972115E-08 |
| Normal-vs-AfricanAmerican |
1.949780E-02 |
| Normal-vs-Asian |
8.39879999992021E-07 |
| Caucasian-vs-AfricanAmerican |
1.471980E-01 |
| Caucasian-vs-Asian |
7.425600E-01 |
| AfricanAmerican-vs-Asian |
2.599800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.5413007515881E-11 |
| Normal-vs-Female |
1.49669999949253E-07 |
| Male-vs-Female |
1.972590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.60850000003366E-07 |
| Normal-vs-Age(41-60Yrs) |
2.47989999646592E-08 |
| Normal-vs-Age(61-80Yrs) |
9.64409663239962E-11 |
| Normal-vs-Age(81-100Yrs) |
2.017500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.522400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.422200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.749200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.644200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.922000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.487800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.159900E-04 |
| Classical-VS-Follicular |
3.726000E-01 |
| Classical-VS-Other |
2.426000E-01 |
| Classical-VS-Normal |
1.27190002974231E-09 |
| Tall-VS-Follicular |
3.101600E-03 |
| Tall-VS-Other |
8.215200E-01 |
| Tall-VS-Normal |
3.43080008846641E-11 |
| Follicular-VS-Other |
7.564100E-02 |
| Follicular-VS-Normal |
1.475210E-03 |
| Other-VS-Normal |
1.116970E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1045000025689E-08 |
| Normal-vs-N1 |
4.29689950287582E-10 |
| N0-vs-N1 |
6.965700E-02 |
|
|
